originally published in The Chattanooga Times Free Press
It’s amazing that Medicare recipients just gained a cap on insulin prices. It’s truly incredible considering the pharmaceutical industry lobbying efforts against any price controls or negotiations. Spearheaded by The Pharmaceutical Research and Manufacturers of America, often known as Pharma, those efforts have been ongoing for years. And in September 2021, it was reported byThe Hill, a media company based in Washington, D.C., that Pharma was launching a seven-figure ad campaign against the proposals moving through Congress to allow negotiation of drug prices.
Continue reading Why Diabetics need to vote – by Deborah Levine